Immunomodulatory effects of bevacizumab in metastatic malignant melanoma

MLA

Aaron S. Mansfield, et al. “Immunomodulatory Effects of Bevacizumab in Metastatic Malignant Melanoma.” Journal of Clinical Oncology, vol. 30, Oct. 2012, p. 82. EBSCOhost, https://doi.org/10.1200/jco.2012.30.30_suppl.82.

APA

Aaron S. Mansfield, Svetomir N. Markovic, & Wendy K. Nevala. (2012). Immunomodulatory effects of bevacizumab in metastatic malignant melanoma. Journal of Clinical Oncology, 30, 82. https://doi.org/10.1200/jco.2012.30.30_suppl.82

Chicago

Aaron S. Mansfield, Svetomir N. Markovic, and Wendy K. Nevala. 2012. “Immunomodulatory Effects of Bevacizumab in Metastatic Malignant Melanoma.” Journal of Clinical Oncology 30 (October): 82. doi:10.1200/jco.2012.30.30_suppl.82.